产品详情
靶点信息
TNF-α (PBMCs) | ||||
13 nM |
In vitro (25°C) | DMSO | 50 mg/mL (182.98 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+2% Tween 80+ddH2O | 2 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 36.6 mL | 183.02 mL | 366.03 mL |
0.5 mM | 7.32 mL | 36.6 mL | 73.21 mL |
1 mM | 3.66 mL | 18.3 mL | 36.6 mL |
5 mM | 0.73 mL | 3.66 mL | 7.32 mL |
*The above data is based on the productmolecular weight 273.2. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10743 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 273.2 |
Formula | C13H11N3O4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 19171-19-8 |
Synonyms | CC-4047, Actimid |
SMILES | C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N |
产品资料
产品标签
Product Questions
Product Questions
Lenalidomide (CC-5013)
Lenalidomide (CC-5013)是Thalidomide的衍生物。在体外,Lenalidomide具有三种主要活性:直接抗肿瘤作用、抑制肿瘤细…
Thalidomide
Thalidomide可以在体内直接抑制bFGF或VEGF诱导的血管生成。
VX-765 (Belnacasan)
VX-765 (Belnacasan)是一种新型的Caspase-1抑制剂,是一种控制两种细胞因子IL-1b和IL-18生成的酶。
Necrostatin-1
Necrostatin-1是一种与ATP竞争的,与受体相互作用的蛋白激酶1(RIPK1)的变构抑制剂(EC50 = 182 nM)。
Obatoclax mesylate (GX15-070)
Obatoclax Mesylate (GX15-070)是一种Bcl-2拮抗剂,拮抗所有抗凋亡Bcl-2家族蛋白(平均IC50,3 umol/L),包括Mcl-1(IC5…
JNJ 26854165
JNJ-26854165是P53激活剂之一,与AraC或阿霉素协同作用,诱导P53介导的凋亡,可能为急性白血病的治疗提供新…